Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1994;3(6):411–414. doi: 10.1155/S0962935194000578

A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-α and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice

K Warzocha 1, J Góra-Tybor 2, M Kwinkowski 3, B Szymańska 3, T Robak 1,✉
PMCID: PMC2365583  PMID: 18475588

Abstract

We investigated the influence of recombinant human tumour necrosis factor alpha (TNF-α) and its derivatives termed muteins III, V, VI—in which the first 3 to 7 amino acids of native TNF-α have been replaced—on the survival time of mice inoculated with leukaemia L1210 or leukaemia P338. TNF-α prolonged the survival of mice with leukaemia L1210 but did not have any therapeutic activity in leukaemia P388-bearing mice. Muteins-treated mice with leukaemia P388 lived longer than animals receiving TNF-α, while those inoculated with leukaemia L1210 did not show any significant prolongation of life compared with the TNF-α treated group. The results presented in this report indicate that the antileukaemic activity of TNF-α is governed at least in part by the nature of the N-terminal amino acids.

Full Text

The Full Text of this article is available as a PDF (409.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blick M., Sherwin S. A., Rosenblum M., Gutterman J. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res. 1987 Jun 1;47(11):2986–2989. [PubMed] [Google Scholar]
  2. Creagan E. T., Kovach J. S., Moertel C. G., Frytak S., Kvols L. K. A phase I clinical trial of recombinant human tumor necrosis factor. Cancer. 1988 Dec 15;62(12):2467–2471. doi: 10.1002/1097-0142(19881215)62:12<2467::aid-cncr2820621202>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  3. Duncombe A. S., Heslop H. E., Turner M., Meager A., Priest R., Exley T., Brenner M. K. Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemia. J Immunol. 1989 Dec 1;143(11):3828–3834. [PubMed] [Google Scholar]
  4. Goh C. R., Porter A. G. Structural and functional domains in human tumour necrosis factors. Protein Eng. 1991 Apr;4(4):385–389. doi: 10.1093/protein/4.4.385. [DOI] [PubMed] [Google Scholar]
  5. Gray P. W., Barrett K., Chantry D., Turner M., Feldmann M. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7380–7384. doi: 10.1073/pnas.87.19.7380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Haranaka K., Satomi N., Sakurai A. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer. 1984 Aug 15;34(2):263–267. doi: 10.1002/ijc.2910340219. [DOI] [PubMed] [Google Scholar]
  7. Kłysik J., Konarzewska-Zglińska A., Gałazka G., Uznański B., Okruszek A., Guga P., Wilk A., Koziołkiewicz M., Tchórzewski H., Zembala M. Synthesis and expression in E. coli of the gene for human tumor necrosis factor (h alpha TNF). Arch Immunol Ther Exp (Warsz) 1991;39(4):349–355. [PubMed] [Google Scholar]
  8. Manda T., Shimomura K., Mukumoto S., Kobayashi K., Mizota T., Hirai O., Matsumoto S., Oku T., Nishigaki F., Mori J. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity. Cancer Res. 1987 Jul 15;47(14):3707–3711. [PubMed] [Google Scholar]
  9. Murase T., Hotta T., Saito H., Ohno R. Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells. Blood. 1987 Feb;69(2):467–472. [PubMed] [Google Scholar]
  10. Peetre C., Gullberg U., Nilsson E., Olsson I. Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor. J Clin Invest. 1986 Dec;78(6):1694–1700. doi: 10.1172/JCI112764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Schall T. J., Lewis M., Koller K. J., Lee A., Rice G. C., Wong G. H., Gatanaga T., Granger G. A., Lentz R., Raab H. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell. 1990 Apr 20;61(2):361–370. doi: 10.1016/0092-8674(90)90816-w. [DOI] [PubMed] [Google Scholar]
  12. Socher S. H., Riemen M. W., Martinez D., Friedman A., Tai J., Quintero J. C., Garsky V., Oliff A. Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor. Proc Natl Acad Sci U S A. 1987 Dec;84(24):8829–8833. doi: 10.1073/pnas.84.24.8829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Soma G., Kitahara N., Tsuji Y., Kato M., Oshima H., Gatanaga T., Inagawa H., Noguchi K., Tanabe Y., Mizuno D. Improvement of cytotoxicity of tumor necrosis factor (TNF) by increase in basicity of its N-terminal region. Biochem Biophys Res Commun. 1987 Oct 29;148(2):629–635. doi: 10.1016/0006-291x(87)90923-5. [DOI] [PubMed] [Google Scholar]
  14. Sugarman B. J., Aggarwal B. B., Hass P. E., Figari I. S., Palladino M. A., Jr, Shepard H. M. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science. 1985 Nov 22;230(4728):943–945. doi: 10.1126/science.3933111. [DOI] [PubMed] [Google Scholar]
  15. Tchorzewski H., Zeman K., Kantorski J., Paleolog E., Kahan M., Feldmann M., Kwinkowski M., Guga P., Szymanska B., Parniewski P. The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitro. Mediators Inflamm. 1993;2(1):41–48. doi: 10.1155/S0962935193000055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tchorzewski H., Zeman K., Paleolog E., Brennan F., Feldmann M., Kahan M., Guga P., Kwinkowski M., Szymanska B., Jarosz J. The effects of tumor necrosis factor (TNF) derivatives on TNF receptors. Cytokine. 1993 Mar;5(2):125–132. doi: 10.1016/1043-4666(93)90051-6. [DOI] [PubMed] [Google Scholar]
  17. Utsumi T., Hung M. C., Klostergaard J. The role of amino functions in recombinant human tumor necrosis factor in expression of biological activity. Mol Immunol. 1992 Jan;29(1):77–81. doi: 10.1016/0161-5890(92)90159-u. [DOI] [PubMed] [Google Scholar]
  18. Warzocha K., Robak T. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice. Acta Haematol Pol. 1992;23(1):55–62. [PubMed] [Google Scholar]
  19. Warzocha K., Robak T., Korycka A., Graczyk J., Pakulska W., Gałazka G., Kłysik J. The influence of recombinant human tumor necrosis factor-alpha, alone and in combination with cyclophosphamide or methotrexate, on leukemia L1210 and normal hematopoiesis in mice. Arch Immunol Ther Exp (Warsz) 1991;39(5-6):587–595. [PubMed] [Google Scholar]
  20. Yamagishi J., Kawashima H., Matsuo N., Ohue M., Yamayoshi M., Fukui T., Kotani H., Furuta R., Nakano K., Yamada M. Mutational analysis of structure--activity relationships in human tumor necrosis factor-alpha. Protein Eng. 1990 Aug;3(8):713–719. doi: 10.1093/protein/3.8.713. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES